Developer docs
API playgroundTry for free, no card

Search company profiles

Austell Pharmaceuticals

Full company profile

uuid0006wra

Namestring
Austell Pharmaceuticals
Websiteurl
austell.co.za
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Austell Pharmaceuticals is an independent, privately held pharmaceutical company headquartered in Johannesburg, South Africa. Founded in 2005 by CEO Suhail Gani, the company supplies a basket of premium branded and generic medicines to the South African market, operating with a workforce of 101-250 employees under a leadership team that includes COO Carl de Witt and CFO Younus Karolia. The company has received institutional backing from Vantage Capital (documented 2014), making it one of a small set of independent mid-sized pharma players serving the local market alongside larger multinational and domestic competitors.

The company's product strategy centers on offering both premium and generic medicines, which suggests a hybrid positioning: higher-margin branded specialty or differentiated products alongside cost-competitive generics that compete on price in volume-driven public and private channels. This dual-model approach is a common playbook for mid-tier pharma distributors and manufacturers seeking to balance margin with market reach in price-sensitive emerging markets. Austell's business model is fundamentally a traditional pharma distribution and/or licensing model, monetizing through sales of registered medicinal products into the South African healthcare ecosystem (pharmacies, hospitals, clinics, wholesalers, and likely some public-sector procurement channels).

The company's revenue mechanics, pricing strategy, channel structure, and customer segmentation are not disclosed in available data — the corporate website returned only a loading/verification screen and no detailed firmographic content was extractable. This limits deeper insight into product mix, therapeutic area focus, and go-to-market specifics. What is established is a durable operating history of nearly two decades, founder-led continuity at the CEO level, and at least one institutional capital event, indicating a business that has survived multiple South African economic cycles but whose current scale, growth rate, and competitive positioning relative to larger players such as Aspen Pharmacare, Adcock Ingram, and Cipla SA cannot be quantified from the available evidence.

Short descriptiontext

Austell Pharmaceuticals is an independent South African pharmaceutical company, founded in 2005 and headquartered in Johannesburg, that supplies a basket of premium branded and generic medicines to the local healthcare market under founder-CEO Suhail Gani.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersJohannesburg, South Africa
HQ citystring
Johannesburg
HQ countrystring
South Africa
HQ regionstring
Africa
Markets served

Serves global market

Keyword5 values
generic pharmaceuticals, branded medicines, pharmaceutical manufacturing, healthcare distribution, pharmaceutical products
Industry4 codes
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIABAA
Small-Molecule Generics (Branded/Unbranded)
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRAOAHAA
Prescription Pharmaceutical (Rx) Wholesale Distribution
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Generic Pharmaceuticals
Social media profiles1 record
Cost components5 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Austell Pharmaceuticals is an independent South African pharmaceutical company that manufactures and distributes a basket of premium and generic medicines to the local market. The company supplies affordable pharmaceutical products across therapeutic categories to wholesalers, pharmacies, and healthcare providers in South Africa.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Premium branded pharmaceutical medicines
CategoryBranded Pharmaceuticals
Description

Premium branded medicines marketed and distributed to South African healthcare providers, pharmacies, and patients.

2Generic pharmaceutical medicines
CategoryGeneric Pharmaceuticals
Description

Affordable generic medicines supplied to South African wholesalers, pharmacies, and healthcare providers as cost-effective therapeutic alternatives.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Largest South African pharmaceutical manufacturer and distributor with both branded and generic portfolios. Directly comparable as a domestic pharma company serving the same market with a similar basket of medicines approach.

TypeDirect peer
Description

South African generics-focused pharmaceutical company marketing a wide basket of prescription and OTC medicines. Comparable scale, business model, and market positioning to Austell.

TypeEmerging player
Description

Indian-headquartered generics manufacturer with growing South African and African distribution. Comparable as a generics-focused competitor targeting similar cost-driven South African demand.

TypeDirect peer
Description

South African arm of Indian generics major Cipla, focused on affordable generic and ARV medicines. Comparable as a generics-heavy competitor in the same South African market.

5Ranbaxy (Sun Pharma South Africa)
TypeEmerging player
Description

Generic-focused multinational with a South African commercial presence. Comparable as a generic-portfolio competitor targeting similar cost-sensitive South African customers.

TypeBroad incumbent
Description

Multinational innovator pharmaceutical company with a significant South African commercial footprint. Comparable as a premium/branded pharmaceutical competitor for the originator segment of Austell's basket.

7Pfizer South Africa
TypeBroad incumbent
Description

Multinational pharmaceutical company with a major South African commercial organization selling branded prescription medicines. Comparable in the premium/innovator side of Austell's portfolio.

TypeRegional player
Description

South African healthcare group with branded prescription, OTC, and consumer health products. Comparable regional pharma presence in the same country with overlapping product baskets.

TypeBroad incumbent
Description

Global pharmaceutical company with established South African operations across branded specialty, generics, and consumer health. Comparable as a broad incumbent competing for the same prescribers and patients.

10Adcock Ingram
TypeDirect peer
Description

Leading South African pharmaceutical company with branded, generic, and OTC portfolios sold through retail pharmacy and hospital channels. Closely comparable business model and product mix to Austell.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Austell Pharmaceuticals

Generic Pharmaceuticalsaustell.co.za

Austell Pharmaceuticals is an independent South African pharmaceutical company, founded in 2005 and headquartered in Johannesburg, that supplies a basket of premium branded and generic medicines to the local healthcare market under founder-CEO Suhail Gani.

What Austell Pharmaceuticals does

Austell Pharmaceuticals is an independent, privately held pharmaceutical company headquartered in Johannesburg, South Africa. Founded in 2005 by CEO Suhail Gani, the company supplies a basket of premium branded and generic medicines to the South African market, operating with a workforce of 101-250 employees under a leadership team that includes COO Carl de Witt and CFO Younus Karolia. The company has received institutional backing from Vantage Capital (documented 2014), making it one of a small set of independent mid-sized pharma players serving the local market alongside larger multinational and domestic competitors.

The company's product strategy centers on offering both premium and generic medicines, which suggests a hybrid positioning: higher-margin branded specialty or differentiated products alongside cost-competitive generics that compete on price in volume-driven public and private channels. This dual-model approach is a common playbook for mid-tier pharma distributors and manufacturers seeking to balance margin with market reach in price-sensitive emerging markets. Austell's business model is fundamentally a traditional pharma distribution and/or licensing model, monetizing through sales of registered medicinal products into the South African healthcare ecosystem (pharmacies, hospitals, clinics, wholesalers, and likely some public-sector procurement channels).

The company's revenue mechanics, pricing strategy, channel structure, and customer segmentation are not disclosed in available data — the corporate website returned only a loading/verification screen and no detailed firmographic content was extractable. This limits deeper insight into product mix, therapeutic area focus, and go-to-market specifics. What is established is a durable operating history of nearly two decades, founder-led continuity at the CEO level, and at least one institutional capital event, indicating a business that has survived multiple South African economic cycles but whose current scale, growth rate, and competitive positioning relative to larger players such as Aspen Pharmacare, Adcock Ingram, and Cipla SA cannot be quantified from the available evidence.

Austell Pharmaceuticals firmographics

Firmographics
Name
Austell Pharmaceuticals
Website
https://austell.co.za
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
101–250 employees
Short description
Austell Pharmaceuticals is an independent South African pharmaceutical company, founded in 2005 and headquartered in Johannesburg, that supplies a basket of premium branded and generic medicines to the local healthcare market under founder-CEO Suhail Gani.
Ownership category
akta.pro rank

Austell Pharmaceuticals industry classification

Industry
Product category
Generic Pharmaceuticals
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIABAA
Small-Molecule Generics (Branded/Unbranded)
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRAOAHAA
Prescription Pharmaceutical (Rx) Wholesale Distribution

Keywords

  • Generic pharmaceuticals
  • Branded medicines
  • Pharmaceutical manufacturing
  • Healthcare distribution
  • Pharmaceutical products

Where Austell Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Johannesburg
HQ country
South Africa
HQ region
Africa

Markets served

Austell Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Austell Pharmaceuticals product offering

Product offering

Core offering

Austell Pharmaceuticals is an independent South African pharmaceutical company that manufactures and distributes a basket of premium and generic medicines to the local market. The company supplies affordable pharmaceutical products across therapeutic categories to wholesalers, pharmacies, and healthcare providers in South Africa.

Differentiator

Problem solved

Functional benefit

Products and services

  • Premium branded pharmaceutical medicines Premium branded medicines marketed and distributed to South African healthcare providers, pharmacies, and patients.
  • Generic pharmaceutical medicines Affordable generic medicines supplied to South African wholesalers, pharmacies, and healthcare providers as cost-effective therapeutic alternatives.

Companies that use Austell Pharmaceuticals

Customer profile

Ideal customer profiles2 records

Austell Pharmaceuticals technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Austell Pharmaceuticals partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights2 records

Austell Pharmaceuticals competitors and assessment

Company assessment

Direct peers

  • Aspen Pharmacare: Largest South African pharmaceutical manufacturer and distributor with both branded and generic portfolios. Directly comparable as a domestic pharma company serving the same market with a similar basket of medicines approach.
  • Pharma Dynamics: South African generics-focused pharmaceutical company marketing a wide basket of prescription and OTC medicines. Comparable scale, business model, and market positioning to Austell.
  • Cipla Medpro South Africa: South African arm of Indian generics major Cipla, focused on affordable generic and ARV medicines. Comparable as a generics-heavy competitor in the same South African market.
  • Adcock Ingram: Leading South African pharmaceutical company with branded, generic, and OTC portfolios sold through retail pharmacy and hospital channels. Closely comparable business model and product mix to Austell.

Emerging players

  • Macleods Pharmaceuticals: Indian-headquartered generics manufacturer with growing South African and African distribution. Comparable as a generics-focused competitor targeting similar cost-driven South African demand.
  • Ranbaxy (Sun Pharma South Africa): Generic-focused multinational with a South African commercial presence. Comparable as a generic-portfolio competitor targeting similar cost-sensitive South African customers.

Broad incumbents

  • Novartis South Africa: Multinational innovator pharmaceutical company with a significant South African commercial footprint. Comparable as a premium/branded pharmaceutical competitor for the originator segment of Austell's basket.
  • Pfizer South Africa: Multinational pharmaceutical company with a major South African commercial organization selling branded prescription medicines. Comparable in the premium/innovator side of Austell's portfolio.
  • Sanofi South Africa: Global pharmaceutical company with established South African operations across branded specialty, generics, and consumer health. Comparable as a broad incumbent competing for the same prescribers and patients.

Regional players

  • Ascendis Health: South African healthcare group with branded prescription, OTC, and consumer health products. Comparable regional pharma presence in the same country with overlapping product baskets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Austell Pharmaceuticals social profiles

Digital presence

Austell Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Austell Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles3 records

Austell Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Austell Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Austell Pharmaceuticals

What does Austell Pharmaceuticals do?

Austell Pharmaceuticals is an independent South African pharmaceutical company that manufactures and distributes a basket of premium and generic medicines to the local market. The company supplies affordable pharmaceutical products across therapeutic categories to wholesalers, pharmacies, and healthcare providers in South Africa.

When was Austell Pharmaceuticals founded?

Austell Pharmaceuticals was founded in 2005. It employs 101 to 250 people.

Where is Austell Pharmaceuticals based?

Austell Pharmaceuticals is headquartered in Johannesburg, South Africa, in the Africa region.

Who are Austell Pharmaceuticals's main competitors?

Direct peers on record are Aspen Pharmacare, Pharma Dynamics, Cipla Medpro South Africa and Adcock Ingram. Emerging players are Macleods Pharmaceuticals and Ranbaxy (Sun Pharma South Africa). Broad incumbents are Novartis South Africa, Pfizer South Africa and Sanofi South Africa. Ascendis Health is listed as a regional player.

Does Austell Pharmaceuticals have an API?

No public API is recorded for Austell Pharmaceuticals.

What industry is Austell Pharmaceuticals in?

Austell Pharmaceuticals's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIABAA, Small-Molecule Generics (Branded/Unbranded). Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Atlanta Journal-ConstitutionAustell approves 30-acre residential subdivisionAustell City Council approved a rezoning on Dec. 6 for nearly 30 acres at the southwest intersection of Old Westside Road and Braswell Circle. The rezoning, from Rural Residential and Light Industrial to Planned Use Development - Residential, will create 97 single-family detached homes, down from 132 proposed in November. The two-story houses will feature craftsman elements and carriage-style garage doors.Atlanta Journal-ConstitutionAustell accepting public input on new vision for downtownAustell is accepting public input on a preliminary downtown plan, proposing $64 million in projects over about 10 years. Nearly 80% of the funds would go to transportation upgrades, including road improvements and streetscaping along Broad Street. Residents can submit comments and take a survey through Sept. 10.Atlanta Journal-ConstitutionAustell to buy new firetruck for $1.3MAustell City Council voted 6-0 on July 12 to buy a new firetruck from Ten-8 Fire and Safety for $1,339,757, funded by 2022 and 2011 SPLOST. The 100-foot aerial apparatus will be delivered in about a year after construction in Wisconsin, with price subject to recalculations due to rising steel and aluminum costs.Atlanta Journal-ConstitutionAustell hearings on tax rate will begin July 12Austell city officials will hold public hearings on July 12 and 26 on a proposed tax increase. The city tentatively adopted a 2021 millage rate that raises property taxes by 4.97 percent while keeping the millage rate at 3.25, unchanged since 2017. The Douglas County portion of the digest has a 0 percent millage rate for 2021.Atlanta Journal-ConstitutionExotic clothing store in Austell cited for operating without a licenseCobb County cited Black Candy, an exotic dancewear store in Austell, for operating without a business license and storing alcohol on unlicensed premises. The store was given 10 days to obtain a license, and a court date is set for July 29. The owner plans a grand opening next month after securing the license.Atlanta Journal-ConstitutionAustell keeps same property tax rateAustell's Fiscal Year 2022 budget was approved 6-0 on June 7, keeping the property tax rate at 3.25 mills. The budget includes a 10% increase in healthcare premiums for employees starting Jan. 1, 2022, and completion of removing the last two pump stations.Atlanta Journal-ConstitutionAustell downtown study begins online March 4Austell officials will hold an online kick-off meeting on March 4 at 5:45 p.m. for the Downtown Austell Livable Centers Initiative study. The city hired a consultant team to develop recommendations for the downtown area, with the online workshop available until April 1.Atlanta Journal-ConstitutionAustell to install school zone speed camerasAustell City Council voted 6-0 to install school zone speed cameras at Garrett Middle School and Hendricks Elementary. Fines are $75 for the first violation and $125 for subsequent ones, with no points or insurance impact, but nonpayment leads to registration denial.Atlanta Journal-ConstitutionComputers coming to Austell Youth Innovation CenterAustell City Council approved 6-0 a proposal to provide up to $10,000 to the Austell Youth Innovation Center for 10 computers and headsets. The center, directed by Pamela Dingle, aims to help local students with schoolwork and improve graduation rates.Atlanta Journal-ConstitutionAustell Senior Center Garden gets TLCCobb County Master Gardeners renovated the Austell Senior Center community garden, cleaning beds and planting a fall crop. The work was done with UGA-Cobb Extension staff and coordinator Renae Lemon, aiming to provide harvest for returning seniors.